BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Carl Zeiss Initiates Landmark Development Project with University of Ulm for Low-voltage Transmission-Electron-Microscopy


2/25/2009 11:01:08 AM

ULM/OBERKOCHEN, Germany & PEABODY, Mass.--(BUSINESS WIRE)--Carl Zeiss SMT today announced the creation of a technology development project that represents one of the most ambitious electron microscopy development efforts to be undertaken in recent years. Together with the University of Ulm and CEOS (Heidelberg), Carl Zeiss SMT has initiated a development partnership for low-voltage transmission electron microscopy. A total of 11.5 million Euros are available to the project, which is initially intended to run for a period of five years. The German Research Foundation (DFG) is contributing 4.2 million Euros. Carl Zeiss is supporting the project with funds totaling 3.7 million Euros.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES